Aatraye Almast Gentzcke is a highly accomplished bioscience entrepreneur and scientist with an impressive background in innovation, digitalization, and product management in healthcare and life sciences. With dual degrees from esteemed institutions including IIT Roorkee, Delhi University, and the University of Cambridge, Aatraye has worked in over 4 countries for both start-ups (Phynova, Roots Analysis) and large companies (Merck KGaA, BioNTech), showcasing her expertise and versatility in the industry. In her last 5 years, Aatraye has focused on digitalization and data analytics, co-creating products that serve the needs of the bioscience industry, including her own failed start-up, ConnectedCareMe. Currently, Aatraye is part of BioNTech, the renowned German-based biotech company responsible for the development of the first authorized COVID mRNA vaccine. As part of her role, Aatraye leverages her expertise in digital and data strategy to identify and solve critical problems that can help expedite drug discovery. Aatraye has an entrepreneurial spirit, having both built and managed teams and communities while working on bold and visionary ideas. Her core values of trust, fairness, transparency, freedom of speech, and curiosity have been instrumental in her success, and her life vision is to make positive change in healthcare, making it accessible as a right rather than a luxury, particularly in medium to low-income countries. A lover of learning, Aatraye continues to expand her skill set, recently adding skiing and swimming to her list of hobbies, and even delving into programming with Python at the start of this year. Aatraye's impressive background and commitment to innovation and social responsibility make her a valuable asset to any team in the healthcare and life sciences industry. #bioscience #entrepreneurship #biotech #digitaltransformation #healthcare #dataanalytics #innovation #failure #leadership #startupculture #corporateinnovation #accessibility #mRNAvaccines #COVID19 #businessofscience #intrapreneurship #podcast #biontech #science #innovativemindset #entrepreneurialjourney #tech #productmanagement #lifevision #learning #Python #research #pharmaceuticals #teammanagement #communitybuilding #boldideas #visionarythinking #trust #fairness #transparency #freedomofspeech #curiosity #inspiration #motivation

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related